Sequential Multiple Assignment Randomized Treatment (SMART) for Bipolar Disorder
Phase of Trial: Phase IV
Latest Information Update: 03 Feb 2017
At a glance
- Drugs Lithium (Primary) ; Valproate semisodium (Primary) ; Lamotrigine; Quetiapine
- Indications Bipolar I disorders; Bipolar II disorders
- Focus Therapeutic Use
- Acronyms SMART
- 24 Jan 2017 Status changed from active, no longer recruiting to completed.
- 21 Jun 2016 Planned End Date changed from 1 Apr 2016 to 1 Dec 2016.
- 21 Jun 2016 Planned primary completion date changed from 1 Apr 2016 to 1 Dec 2016.